Phase 2 study
Recruiting Phase 2
This trial at a glance
Where this trial is running
| Site | City | State or country | Status at this site |
|---|---|---|---|
| Marea Site 103 | Canberra | ACT | Active not recruiting |
| Marea Site 105 | Kanwal | NSW | Active not recruiting |
| Marea Site 107 | Merewether | NSW | Active not recruiting |
| Marea Site 106 | Miranda | NSW | Active not recruiting |
| Marea Site 109 | Wollongong | NSW | Active not recruiting |
| Marea Site 108 | Herston | QLD | Active not recruiting |
| Marea Site 104 | Milton | QLD | Recruiting |
| Marea Site 111 | Leabrook | SA | Recruiting |
| Marea Site 102 | Clayton | VIC | Recruiting |
| Marea Site 110 | Heidelberg Heights | VIC | Active not recruiting |
| Marea Site 113 | Hoppers Crossing | VIC | Active not recruiting |
| Marea Site 101 | Nedlands | WA | Recruiting |
| Marea Site 112 | Perth | WA | Recruiting |
voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice
Who can join
The official eligibility criteria
Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.
Inclusion Criteria:
* Elevated fasting TGs and RC
* Elevated nonfasting TGs and RC
* Part A only: Fasting LDL-C ≥ 50 mg/dL (≥ 1.29 mmol/L) and ≤ 130 mg/dL (≤ 3.36 mmol/L)
* Willingness to provide informed consent and comply with the intervention and all study assessments
* Stable diet for a minimum of 3 months prior to screening and with no plans to change during screening or trial participation
* Stable drug regimen (if relevant) prior to screening visit and no planned changes after enrollment; Part B only: adjustment of lipid-lowering therapy during the diet/lifestyle run-in period is permitted
Exclusion Criteria:
* Acute or chronic liver disease
* Part A only: TG concentration ≥880mg/dl; Part B only: TG concentration ≥2000 mg/dL
* History of type 1 diabetes mellitus or history of diabetic ketoacidosis
* Newly diagnosed T2DM
* Participants with known active hepatitis A, B, or C
* Uncontrolled hypothyroidism
* Part B only: recent history of active pancreatitis
* Part B only: genetically confirmed Familial Chylomicronemia Syndrome (FCS) diagnosis due to biallelic loss of function mutations in LPL or GPIHBP1
* Part B only: use of ANGPTL3 and ApoC-III inhibitors
* Any condition that prevents the participant from complying with study procedures
Dates on the record
Results, publications and the official record
- No results are posted on the official record yet.
- No publications are listed on the official record yet.
- Official record and contacts on ClinicalTrials.gov – contact details for each site are kept there, and are not copied onto this page.
Sources and dates
- ClinicalTrials.gov – the record this page reformats
- ClinicalTrials.gov processing date: 2 September 2026.
- This page last checked by Voxsanity: 11 October 2026.
Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.
Not medical advice.
Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.
Letter for your doctor
A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.